Trxade Group Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
955.90
1,496.20
2,912.50
2,481.90
2,931.30
3,831.80
Cost of Goods Sold (COGS) incl. D&A
944.10
440.00
189.80
16.40
-
449
Gross Income
11.80
1,056.20
2,722.70
2,465.50
-
3,382.70
SG&A Expense
2,095.80
2,487.70
2,859.80
3,449.50
2,536.20
3,470.30
EBIT
2,084.00
1,431.50
-
984.00
395.10
87.60
Unusual Expense
-
576.40
-
37.60
16.60
7.40
Non Operating Income/Expense
-
-
-
-
67.50
161.60
Interest Expense
7.30
4.20
119.50
151.50
157.10
57.50
Pretax Income
2,091.30
2,012.00
256.60
1,173.10
289.00
9
Consolidated Net Income
2,091.30
2,012.00
256.60
1,173.10
289.00
9
Net Income
2,091.30
2,012.00
256.60
1,173.10
289.00
9
Net Income After Extraordinaries
2,091.30
2,012.00
604.00
413.90
289.00
9
Net Income Available to Common
2,091.30
2,012.00
1,117.20
2,957.70
289.00
9
EPS (Basic)
150.00
0.07
0.04
0.09
0.01
-
Basic Shares Outstanding
14.10
29,831.00
31,315.70
31,544.90
31,955.40
32,260.60
EPS (Diluted)
148.30
0.07
0.04
0.09
0.01
-
Diluted Shares Outstanding
14.10
29,831.00
31,315.70
31,544.90
34,086.30
34,958.50
EBITDA
2,080.00
1,426.70
133.30
984.00
395.10
87.60

About Trxade Group

View Profile
Address
3840 Land O'Lakes Boulevard
Land O' Lakes Florida 34639
United States
Employees -
Website http://www.trxadegroup.com
Updated 07/08/2019
Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings.